Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Europe Bio Fertilizer Market

ID: MRFR/Agri/46661-HCR
128 Pages
Snehal Singh
Last Updated: April 06, 2026
Europe Bio Fertilizer Market Size, Share, Industry Trend & Analysis Research Report By Type (Nitrogen Fixing, Phosphate Solubilizing, Others), By Crop Type (Cereals & Grains, Pulses & Oilseeds, Fruits & Vegetables), By Form (Dry, Liquid), By Application (Leaf Treatment, Root Immersion, Plant Rooting, Others), By Microorganism Type (Rhizobium, Azotobacter, Azospirillum, Pseudomonas, Bacillus, VAM, Others) and By Regional (Germany, UK, France, Russia, Italy, Spain, Rest of Europe) - Forecast to 2035.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Europe Bio Fertilizer Market Infographic
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Application (USD Million)
      1. 4.1.1 Soil Fertility Enhancement
      2. 4.1.2 Plant Growth Promotion
      3. 4.1.3 Disease Resistance
      4. 4.1.4 Nutrient Supply
      5. 4.1.5 Soil Health Improvement
    2. 4.2 Medical Device, BY Type (USD Million)
      1. 4.2.1 Nitrogen Fixing Bacteria
      2. 4.2.2 Phosphate Solubilizing Bacteria
      3. 4.2.3 Mycorrhizal Fungi
      4. 4.2.4 Organic Fertilizers
      5. 4.2.5 Compost
    3. 4.3 Medical Device, BY Formulation (USD Million)
      1. 4.3.1 Liquid Bio Fertilizers
      2. 4.3.2 Granular Bio Fertilizers
      3. 4.3.3 Powder Bio Fertilizers
      4. 4.3.4 Pelleted Bio Fertilizers
    4. 4.4 Medical Device, BY End Use (USD Million)
      1. 4.4.1 Cereals and Grains
      2. 4.4.2 Fruits and Vegetables
      3. 4.4.3 Pulses and Oilseeds
      4. 4.4.4 Turf and Ornamentals
    5. 4.5 Medical Device, BY Distribution Channel (USD Million)
      1. 4.5.1 Direct Sales
      2. 4.5.2 Online Sales
      3. 4.5.3 Retail Sales
      4. 4.5.4 Wholesale
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 BASF SE (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Novozymes A/S (DK)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Syngenta AG (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Yara International ASA (NO)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 BioWorks, Inc. (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 AgriLife (IT)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Rizobacter Argentina S.A. (AR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Koppert Biological Systems (NL)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Biolchim S.p.A. (IT)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 EUROPE MARKET ANALYSIS BY APPLICATION
    3. 6.3 EUROPE MARKET ANALYSIS BY TYPE
    4. 6.4 EUROPE MARKET ANALYSIS BY FORMULATION
    5. 6.5 EUROPE MARKET ANALYSIS BY END USE
    6. 6.6 EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    7. 6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF MEDICAL DEVICE
    10. 6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    12. 6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
    16. 6.16 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
    17. 6.17 MEDICAL DEVICE, BY FORMULATION, 2024 (% SHARE)
    18. 6.18 MEDICAL DEVICE, BY FORMULATION, 2024 TO 2035 (USD Million)
    19. 6.19 MEDICAL DEVICE, BY END USE, 2024 (% SHARE)
    20. 6.20 MEDICAL DEVICE, BY END USE, 2024 TO 2035 (USD Million)
    21. 6.21 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    22. 6.22 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY TYPE, 2026-2035 (USD Million)
      3. 7.2.3 BY FORMULATION, 2026-2035 (USD Million)
      4. 7.2.4 BY END USE, 2026-2035 (USD Million)
      5. 7.2.5 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Europe Medical Device Market Segmentation

Medical Device By Application (USD Million, 2026-2035)

  • Soil Fertility Enhancement
  • Plant Growth Promotion
  • Disease Resistance
  • Nutrient Supply
  • Soil Health Improvement

Medical Device By Type (USD Million, 2026-2035)

  • Nitrogen Fixing Bacteria
  • Phosphate Solubilizing Bacteria
  • Mycorrhizal Fungi
  • Organic Fertilizers
  • Compost

Medical Device By Formulation (USD Million, 2026-2035)

  • Liquid Bio Fertilizers
  • Granular Bio Fertilizers
  • Powder Bio Fertilizers
  • Pelleted Bio Fertilizers

Medical Device By End Use (USD Million, 2026-2035)

  • Cereals and Grains
  • Fruits and Vegetables
  • Pulses and Oilseeds
  • Turf and Ornamentals

Medical Device By Distribution Channel (USD Million, 2026-2035)

  • Direct Sales
  • Online Sales
  • Retail Sales
  • Wholesale

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035